April 17, 2021
During this annual conference, African American female youth will be introduced to careers in science, technology, engineering, and math, and they will meet professional women practicing in these fields. The keynote speaker, Dr. Hadiyah-Nicole Green, will share her groundbreaking work using nanotechnology to treat cancer.
Sacred Sistahs STEM Conference for African American girls is celebrating its 10th year anniversary this year, so join the organization and Harvey Mudd College's Office of Community Engagement (OCE) to celebrate!
Dr. Hadiyah-Nicole Green, one of the first African American women to earn a PhD in physics, holds the distinction of being only the second African American woman and the fourth African American to receive a PhD in physics from the University of Alabama at Birmingham (UAB). She humbly served as Miss Alabama A&M University 2002-2003 and is a proud member of Delta Sigma Theta Sorority, Inc. Her professional expertise lies at the intersection of nanotechnology, immunotherapy and precision medicine. She is an assistant professor at Morehouse School of Medicine in the Department of Surgery and the recipient of a $1.1 million grant from the U.S. Department of Veterans Affairs. Green has been highlighted in the media and has been featured among STEM leaders, influencers and entrepreneurs by a wide variety of organizations and publications.
Notably, Green developed a cancer treatment that uses lasers and nanotechnology to kill cancer in mice in just 15 days after a single 10-minute treatment with no observable side effects. Additionally, she has developed a 4-in-1 platform for early detection, imaging, targeting and selective treatment of head and neck cancers.
She founded a 501(c)(3) non-profit organization, the Ora Lee Smith Cancer Research Foundation, to raise the funding for human clinical trials and ensure that this treatment can be made affordable for everyone. Green has intertwined her life’s purpose into the mission of the organization: to change the way cancer is treated and reduce the suffering of cancer patients by providing a treatment that is accessible, affordable and most importantly, effective.